chartexchange

Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

GlobeNewswire Inc. | Nov 4, 2026 7:05 AM EST

MOUNTAIN VIEW, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tuesday, November 10, 2026, at 2:30 p.m. ET.

Read original article